查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1815471

2025年全球关节内粘稠补充疗法市场报告

Viscosupplementation Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年关节内粘稠补充疗法市场将快速成长，到2029年将达到66.7亿美元，复合年增长率为10.3%。预测期内的成长可归因于监管支持、替代支付模式、医疗保健支出的增加、研发以及适应症的扩大。预测期内的主要趋势包括基于结果的支付模式、患者教育计划、生物标记开发、基因治疗研究以及基于价值的护理模式。

未来五年的预测成长率为10.3%，较我们先前对该市场的预测略有下降0.3%。下降的主要原因是美国与其他国家之间关税的影响。关税上调可能会增加来自瑞典和韩国的透明质酸注射剂的成本，从而损害美国整形外科诊所的利益，导致骨关节炎疼痛治疗的延误和关节注射费用的增加。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，关税上调的影响可能更为广泛。

骨关节炎盛行率的不断上升预计将在不久的将来成为关节内粘稠补充疗法市场的主要驱动力。骨关节炎是一种退化性关节疾病，也是常见的关节炎类型，其表现为关节破坏，尤其是在髋部、膝盖和手部等部位。关节内粘稠补充疗法治疗包括将透明质酸直接注射到骨关节，以缓解疼痛并促进骨骼运动。根据美国公共卫生机构疾病管制与预防中心 (CDC) 的数据，预计到 2040 年，关节炎将影响 7,840 万 18 岁及以上的美国成年人。这凸显了骨关节炎盛行率的不断上昇在推动关节内粘稠补充疗法市场成长轨迹方面发挥的关键作用。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 关节内粘稠补充疗法：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球关节内粘稠补充疗法市场：增长率分析
  • 全球关节内粘稠补充疗法市场表现：规模与成长，2019-2024 年
  • 全球关节内粘稠补充疗法市场预测：规模与成长，2024-2029 年，2034 年
  • 全球关节内粘稠补充疗法：总目标市场（TAM）

第六章 市场细分

  • 全球关节内粘稠补充疗法市场：按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 单次注射关节内粘稠补充疗法
  • 三次注射关节内粘稠补充疗法
  • 5次注射关节内粘稠补充疗法
  • 全球关节内粘稠补充疗法市场：按来源、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 鸟类衍生
  • 非禽类起源
  • 全球关节内粘稠补充疗法市场：依透明质酸划分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 标准玻尿酸
  • 稳定玻尿酸
  • 全球关节内粘稠补充疗法市场：按应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 膝关节骨关节炎
  • 髋关节骨关节炎
  • 手部骨关节炎
  • 全球关节内粘稠补充疗法市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 其他最终用户
  • 全球关节内粘稠补充疗法市场：按单次注射黏液关节内粘稠补充疗法、类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 透明质酸类产品
  • 不含玻尿酸的产品
  • 全球关节内粘稠补充疗法市场：按三种注射黏液关节内粘稠补充疗法细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 透明质酸类产品
  • 组合产品
  • 全球关节内粘稠补充疗法市场：按五种注射黏液关节内粘稠补充疗法细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 透明质酸类产品
  • 组合产品

第七章 区域和国家分析

  • 全球关节内粘稠补充疗法市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球关节内粘稠补充疗法市场：依国家、表现及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 关节内粘稠补充疗法市场：竞争格局
  • 关节内粘稠补充疗法市场：公司简介
    • Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bioventus LLC Overview, Products and Services, Strategy and Financial Analysis
    • Zimmer Biomet Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Aptissen SA
  • Smith & Nephew Plc.
  • Flexion Therapeutics Inc.
  • Regen Lab SA
  • OrthogenRx Inc.
  • Fidia Farmaceutici SPA
  • Ferring Pharmaceuticals
  • Laboratoires VIVACY
  • Allergan
  • Hyalgan
  • Synvisc
  • Euflexxa
  • Sanofi SA
  • Wellchem Pharmaceuticals Pte Ltd.
  • SingHealth Group

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年关节内粘稠补充疗法市场：提供新机会的国家
  • 2029 年关节内粘稠补充疗法市场：细分市场带来新机会
  • 2029年关节内粘稠补充疗法市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r23832u

Viscosupplementation involves the injection of hyaluronic acid gel directly into the joint to alleviate friction during movement. Hyaluronic acid, naturally present in synovial fluid surrounding joints, aids in reducing friction during joint motion.

The primary types of viscosupplementation include single-injection, three-injection, and five-injection methods. Single-injection viscosupplementation entails a direct injection of hyaluronic acid into the knee's diarthrodial joints, restoring the synovial fluid's rheological properties to generate anti-inflammatory and analgesic effects. Hyaluronic acid variations such as standard and stabilized forms, sourced from avian and non-avian origins, are used to address various osteoarthritic conditions such as knee, hip, and hand osteoarthritis. These treatments are administered across diverse healthcare settings, including hospitals, ambulatory surgical centers, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The viscosupplementation market research report is one of a series of new reports from The Business Research Company that provides viscosupplementation market statistics, including viscosupplementation industry global market size, regional shares, competitors with a viscosupplementation market share, detailed viscosupplementation market segments, market trends, and opportunities, and any further data you may need to thrive in the viscosupplementation industry. This viscosupplementation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The viscosupplementation market size has grown strongly in recent years. It will grow from $4.1 billion in 2024 to $4.5 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to aging population, rising obesity rates, enhanced insurance coverage, growing awareness, patient preference, increased osteoarthritis cases.

The viscosupplementation market size is expected to see rapid growth in the next few years. It will grow to $6.67 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to regulatory support, alternative payment models, increased healthcare expenditure, research and development, expansion of indications. Major trends in the forecast period include outcome-based payment models, patient education initiatives, biomarker development, gene therapy research, value-based care models.

The forecast of 10.3% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations could hamper U.S. orthopedic clinics by increasing costs of hyaluronic acid injectables sourced from Sweden and South Korea, leading to delayed osteoarthritis pain management and higher joint injection procedure expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of osteoarthritis is poised to be a significant driver for the viscosupplementation market in the foreseeable future. Osteoarthritis, a degenerative joint disease and a common form of arthritis, manifests in the breakdown of joints, particularly in areas such as the hips, knees, and hands. Viscosupplementation treatment, involving the direct injection of hyaluronic acid into bone joints, serves to alleviate pain and enhance smooth bone movement. According to the Centers for Disease Control and Prevention (CDC), an American public health service organization, a projected 78.4 million adults aged 18 years and older in the USA are expected to be afflicted by arthritis by the year 2040. This underscores the pivotal role of the rising prevalence of osteoarthritis in propelling the growth trajectory of the viscosupplementation market.

Anticipated growth in healthcare expenditure is set to foster the expansion of the viscosupplementation market in the coming years. Healthcare expenditure, denoting the total spending on healthcare costs, encompasses the financial outlay on healthcare-related goods and services within a specific healthcare system or economy. The surge in healthcare expenditure plays a pivotal role in advancing the broader adoption and increased accessibility of viscosupplementation. This support extends to various aspects, including research, training, infrastructure development, and coverage by healthcare plans, ultimately benefiting individuals grappling with joint-related issues. As of November 2022, the Canadian Institute for Health Information, a U.S.-based not-for-profit organization, reported a notable increase in healthcare expenditure to 0.8%, reaching $331 billion in 2022, compared to 7.6% in 2021. Consequently, the upward trajectory of healthcare expenditure emerges as a driving force behind the growth of the viscosupplementation market.

The viscosupplementation market is witnessing a surge in popularity driven by advancements in technology. Companies within this market are strategically embracing new technologies to maintain their competitive edge. In August 2021, Seikagaku Corporation, a prominent Japanese pharmaceutical firm, unveiled HyLink, an innovative viscosupplement designed for intra-articular single injection to address knee osteoarthritis. HyLink incorporates cross-linking technology, a method used to create a long-lasting cross-linked hyaluronate hydrogel that effectively persists in the joint cavity, establishing it as a durable treatment solution. This move reflects Seikagaku Corporation's commitment to staying at the forefront of technological developments within the viscosupplementation sector.

Leading companies in the viscosupplementation market are actively pursuing innovation to secure a competitive advantage. A notable example is Nuvo Pharmaceuticals Inc., a Canada-based pharmaceutical company, which, in January 2021, introduced NeoVisc+ 2 mL and NeoVisc ONE 4 mL in the Canadian market. These products are hyaluronic acid (HA) viscosupplements specifically designed to address pain relief and enhance joint functionality in patients with degenerative or mechanical arthropathy of the knee, commonly associated with osteoarthritis. The launch of NeoVisc+ 2 mL and NeoVisc ONE 4 mL underscores Nuvo Pharmaceuticals Inc.'s dedication to delivering cutting-edge treatment options for knee pain and osteoarthritis, contributing to the overall growth of the viscosupplementation market in Canada.

In December 2021, Avanos Medical Inc., a medical technology company based in the United States, successfully completed the acquisition of OrthogenRx Inc. for a total transaction value of $160 million. This strategic move significantly expanded, diversified, and enhanced Avanos Medical Inc.'s chronic pain product portfolio, specifically by incorporating treatment options for individuals with knee osteoarthritis. The acquisition was strategically aligned with the company's objective to fortify its partnerships with healthcare providers on a global scale, particularly in the realm of musculoskeletal pain treatment. OrthogenRx Inc., a U.S.-based medical device company with expertise in viscosupplementation therapies for knee osteoarthritis, played a pivotal role in reinforcing Avanos Medical Inc.'s position in this therapeutic space.

Major companies operating in the viscosupplementation market include Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Zimmer Biomet, Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi S.A., Wellchem Pharmaceuticals Pte Ltd., SingHealth Group

North America was the largest region in the viscosupplementation market in 2024. The regions covered in the viscosupplementation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the viscosupplementation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viscosupplementation market consists of revenues earned by entities by providing viscosupplementation therapy services such as plasma-rich platelet (PRP) injections and stem cell injections that are used in osteoarthritis (OA) treatment procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The viscosupplementation market also includes sales of hyaluronans and hylan injection preparations to provide viscosupplementation therapy services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viscosupplementation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viscosupplementation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viscosupplementation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viscosupplementation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Single Injection Viscosupplementation; Three Injection Viscosupplementation; Five Injection Viscosupplementation
  • 2) By Source: Avian Origin; Non-Avian Origin
  • 3) By Hyaluronic Acids: Standard Hyaluronic Acid; Stabilized Hyaluronic Acid
  • 4) By Application: Knee Osteoarthritis; Hip Osteoarthritis; Hand Osteoarthritis
  • 5) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
  • Subsegments:
  • 1) By Single Injection Viscosupplementation: Hyaluronic Acid-Based Products; Non-Hyaluronic Acid Products
  • 2) By Three Injection Viscosupplementation: Hyaluronic Acid-Based Products; Combination Products
  • 3) By Five Injection Viscosupplementation: Hyaluronic Acid-Based Products; Combination Products
  • Companies Mentioned: Seikagaku Corporation; Anika Therapeutics Inc.; Bioventus LLC; Zimmer Biomet; Johnson & Johnson Services Inc.; Aptissen S.A.; Smith & Nephew Plc.; Flexion Therapeutics Inc.; Regen Lab SA; OrthogenRx Inc.; Fidia Farmaceutici S.P.A; Ferring Pharmaceuticals; Laboratoires VIVACY; Allergan; Hyalgan; Synvisc; Euflexxa; Sanofi S.A.; Wellchem Pharmaceuticals Pte Ltd.; SingHealth Group
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Viscosupplementation Market Characteristics

3. Viscosupplementation Market Trends And Strategies

4. Viscosupplementation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Viscosupplementation Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Viscosupplementation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Viscosupplementation Market Growth Rate Analysis
  • 5.4. Global Viscosupplementation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Viscosupplementation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Viscosupplementation Total Addressable Market (TAM)

6. Viscosupplementation Market Segmentation

  • 6.1. Global Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Injection Viscosupplementation
  • Three Injection Viscosupplementation
  • Five Injection Viscosupplementation
  • 6.2. Global Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Avian Origin
  • Non-Avian Origin
  • 6.3. Global Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Hyaluronic Acid
  • Stabilized Hyaluronic Acid
  • 6.4. Global Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Hand Osteoarthritis
  • 6.5. Global Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users
  • 6.6. Global Viscosupplementation Market, Sub-Segmentation Of Single Injection Viscosupplementation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hyaluronic Acid-Based Products
  • Non-Hyaluronic Acid Products
  • 6.7. Global Viscosupplementation Market, Sub-Segmentation Of Three Injection Viscosupplementation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hyaluronic Acid-Based Products
  • Combination Products
  • 6.8. Global Viscosupplementation Market, Sub-Segmentation Of Five Injection Viscosupplementation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hyaluronic Acid-Based Products
  • Combination Products

7. Viscosupplementation Market Regional And Country Analysis

  • 7.1. Global Viscosupplementation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Viscosupplementation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Viscosupplementation Market

  • 8.1. Asia-Pacific Viscosupplementation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Viscosupplementation Market

  • 9.1. China Viscosupplementation Market Overview
  • 9.2. China Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Viscosupplementation Market

  • 10.1. India Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Viscosupplementation Market

  • 11.1. Japan Viscosupplementation Market Overview
  • 11.2. Japan Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Viscosupplementation Market

  • 12.1. Australia Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Viscosupplementation Market

  • 13.1. Indonesia Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Viscosupplementation Market

  • 14.1. South Korea Viscosupplementation Market Overview
  • 14.2. South Korea Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Viscosupplementation Market

  • 15.1. Western Europe Viscosupplementation Market Overview
  • 15.2. Western Europe Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Viscosupplementation Market

  • 16.1. UK Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Viscosupplementation Market

  • 17.1. Germany Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Viscosupplementation Market

  • 18.1. France Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Viscosupplementation Market

  • 19.1. Italy Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Viscosupplementation Market

  • 20.1. Spain Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Viscosupplementation Market

  • 21.1. Eastern Europe Viscosupplementation Market Overview
  • 21.2. Eastern Europe Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Viscosupplementation Market

  • 22.1. Russia Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Viscosupplementation Market

  • 23.1. North America Viscosupplementation Market Overview
  • 23.2. North America Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Viscosupplementation Market

  • 24.1. USA Viscosupplementation Market Overview
  • 24.2. USA Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Viscosupplementation Market

  • 25.1. Canada Viscosupplementation Market Overview
  • 25.2. Canada Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Viscosupplementation Market

  • 26.1. South America Viscosupplementation Market Overview
  • 26.2. South America Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Viscosupplementation Market

  • 27.1. Brazil Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Viscosupplementation Market

  • 28.1. Middle East Viscosupplementation Market Overview
  • 28.2. Middle East Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Viscosupplementation Market

  • 29.1. Africa Viscosupplementation Market Overview
  • 29.2. Africa Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Viscosupplementation Market Competitive Landscape And Company Profiles

  • 30.1. Viscosupplementation Market Competitive Landscape
  • 30.2. Viscosupplementation Market Company Profiles
    • 30.2.1. Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bioventus LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Zimmer Biomet Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Viscosupplementation Market Other Major And Innovative Companies

  • 31.1. Aptissen S.A.
  • 31.2. Smith & Nephew Plc.
  • 31.3. Flexion Therapeutics Inc.
  • 31.4. Regen Lab SA
  • 31.5. OrthogenRx Inc.
  • 31.6. Fidia Farmaceutici S.P.A
  • 31.7. Ferring Pharmaceuticals
  • 31.8. Laboratoires VIVACY
  • 31.9. Allergan
  • 31.10. Hyalgan
  • 31.11. Synvisc
  • 31.12. Euflexxa
  • 31.13. Sanofi S.A.
  • 31.14. Wellchem Pharmaceuticals Pte Ltd.
  • 31.15. SingHealth Group

32. Global Viscosupplementation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Viscosupplementation Market

34. Recent Developments In The Viscosupplementation Market

35. Viscosupplementation Market High Potential Countries, Segments and Strategies

  • 35.1 Viscosupplementation Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Viscosupplementation Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Viscosupplementation Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer